Skip to content
healthcare.dev

SAJAZIR

NDC 70709-013, ICATIBANT, injection, from Cycle Pharmaceuticals Ltd-Uk.

Product NDC
70709-013
Status
Listed
Labeler
Cycle Pharmaceuticals Ltd-Uk
Dosage form
INJECTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212446
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70709-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ICATIBANT ACETATE30 mg/3mL

Pharmacologic classes

Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]

Package NDCNDC-11Package
70709-013-01707090013011 SYRINGE, GLASS in 1 CARTON (70709-013-01) / 3 mL in 1 SYRINGE, GLASS
70709-013-03707090013033 SYRINGE, GLASS in 1 CARTON (70709-013-03) / 3 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1756aca0-21a1-4898-8d6c-9666738db45c

Use it

Look up 70709-013 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70709-013 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70709-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.